Case Reports

skingenix

Case Reports

1.	(2009) R. Pangayoman, et al. Burns Regenerative Medicine and Therapy (MEBT/MEBO) in Serious Electrical Burn Treatment. J of Wound Technology 2009; No. 4:25-28
2.	(2004) Ky Young Cho, Soo Jung Lee, Jin Sik Burm, Eun Ae Park. Successful Combined Treatment with Total Parenteral Nutrition Fluid Extravasation Injuries in Preterm Infants. J Korean Med Sci 2007; 22: 588-94
3.	(2003) BS Atiyeh, R Dham, MF Yassin, KA El-Musa. Treatment of Toxic Epidermal Necrolysis With Moisture-Retentive Ointment: A Case Report and Review of the Literature. Dermatol Surg. 2003; 29(2):185-188.
4.	(2003) George Alexander, Nebojsa Rajacic, Mohammed K. Ebrahim, Ibrahim Ghoneim. MEBO and Hot Bitumen Burns. Burns 2003; 29(8): 863-865.

The Skingenix, Inc. website has been designed for the audience worldwide. This website contains information about products which may or may not be available in different countries. In addition, the official approval or market clearance for indications of use may also differ per each country. Please consult individual country sites for approved uses and any applicable restrictions.The research data disclosed in this website is wholly for the purpose of scientific information exchange and is not intended for marketing or promotional uses.

Please note that Skingenix's drug product MEBO® Wound Ointment has not been approved by the Food and Drug Administration for any indication of use in the United States. It is currently under the status of Investigational New Drug (Phase II) for patients with burn injuries, venous stasis ulcers and diabetic foot ulcers.